Word: model
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...turn the entire history of life into a video game without wrestling with some heavy philosophical questions, but Wright seems to have steered a middle course that avoids both religious and evolutionary blasphemy. You could read Spore equally easily as a model of evolution or of intelligent design, with you in the role of Intelligent Designer. (O.K., it's a bit blasphemous.) "A game like this can actually generate interesting, meaningful conversations between people," Wright says. "I think that's the best thing...
...conference address, is results: "What we want to see is research that is going to change the number of women that are diagnosed with, or more importantly, die of, breast cancer within the foreseeable future." Others, like the Multiple Myeloma Research Foundation (MMRF), are trying a no-nonsense business model to speed drug development...
Last year Armstrong persuaded the advocate community in Texas to play nice in support of a referendum to spend $3 billion fighting cancer over the next 10 years. The passage of the proposal was a huge victory in a spend-wary state, and perhaps it was a model for others. The program makes cancer prevention and screening key components, which saves the state money in the long...
SU2C is not the only independent group shaking things up. The Multiple Myeloma Research Foundation used a pay-for-results funding model that has more to do with Silicon Valley than Big Pharma to support research that in four years got four new treatments to patients--Thalomid, Velcade, Revlimid and Doxil. That's about six years faster than the decade it usually takes for such drug development and rollout. Multiple myeloma is a rare cancer of the bone marrow that sickens about 20,000 Americans each year--precisely the uncommon form of the disease that often falls into the research...
...MMRF made sure it got the most from its grant dollars by adopting an enforced-collaboration model in 2004, linking work at four cancer centers into a consortium managed by PricewaterhouseCoopers and providing them all with patients, tissue samples and a set of targets and goals. "The odds of a cure coming from one center are nil," Giusti says. "You need a mutual fund to fight cancer." From not having a single drug in the pipeline, the MMRF now has 30, half of them in clinical trials. The average lifespan of a multiple-myeloma patient has been extended by three...